Loading...
Loading...
DiaSorin SpA/ADR
DiaSorin SpA/ADR. Spoken Alpha tracks DSRNY's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks DSRNY's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 50% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for DSRNY.
curl https://api.spokenalpha.com/v1/companies/DSRNY| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $4.07 | $3.03 | +34.2% | -1.9% | -3.5% |
| Q4 FY2026 | $4.36 | $3.20 | +36.1% | -3.0% | -0.2% |
| Q3 FY2026 | $4.52 | $3.21 | +40.9% | +1.1% | +2.9% |
| Q2 FY2026 | $4.45 | $3.31 | +34.5% | +6.3% | +4.0% |
| Q1 FY2025 | $4.22 | $3.13 | +34.7% | +2.0% | +4.8% |
| Q4 FY2025 | $4.56 | $3.23 | +41.2% | -3.6% | -5.4% |
| Q3 FY2025 | $4.64 | $3.34 | +38.9% | -1.1% | -1.5% |
| Q2 FY2025 | $4.40 | $3.33 | +32.1% | +3.7% | +2.2% |
| Q1 FY2024 | $4.50 | $3.45 | +30.4% | +2.2% | +1.9% |
| Q4 FY2024 | $4.89 | $3.41 | +43.5% | -0.4% | -0.7% |